Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;16(5):441-8.
doi: 10.2217/pgs.15.10.

Pharmacogenomic assessment of Mexican and Peruvian populations

Sharon Marsh  1 , Cristi R King, Derek J Van Booven, Jane Y Revollo, Robert H Gilman, Howard L McLeod
Affiliations

Pharmacogenomic assessment of Mexican and Peruvian populations

Sharon Marsh et al. Pharmacogenomics. 2015.

Abstract

Background: Clinically relevant polymorphisms often demonstrate population-specific allele frequencies. Central and South America remain largely uncategorized in the context of pharmacogenomics.

Materials & methods: We assessed 15 polymorphisms from 12 genes (ABCB1 3435C>T, ABCG2 Q141K, CYP1B1*3, CYP2C19*2, CYP3A4*1B, CYP3A5*3C, ERCC1 N118N, ERCC2 K751Q, GSTP1 I105V, TPMT 238G>C, TPMT 460G>A, TPMT 719A>G, TYMS TSER, UGT1A1*28 and UGT1A1 -3156G>A) in 81 Peruvian and 95 Mexican individuals.

Results: Six polymorphism frequencies differed significantly between the two populations: ABCB1 3435C>T, CYP1B1*3, GSTP1 I105V, TPMT 460G>A, UGT1A1*28 and UGT1A1 -3156G>A. The pattern of observed allele frequencies for all polymorphisms could not be accurately estimated from any single previously studied population.

Conclusion: This highlights the need to expand the scope of geographic data for use in pharmacogenomics studies.

Keywords: Hispanic; Mexico; Peru; genotype; pharmacogenomics; polymorphism; population.

PubMed Disclaimer

Figures

Figure 1
Figure 1. TPMT allele frequency (combined *2, *3A, *3B and *3C) distribution in North and South America [–59]
USA Caucasian (blue) represents the reference frequency (0.04) [56]. Green = between 0.5 and 2× the reference frequency, yellow = allele frequencies greater than 2× the reference frequency, gray = unknown frequency. Allele frequencies are listed in Supplementary Table 1.
See this image and copyright information in PMC

References

    1. Kidd KK, Pakstis AJ, Yun L. An historical perspective on the world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Hum Genet. 2014;133(4):431–433. - PubMed
    1. Stathias V, Sotiris GR, Karagiannidis I, et al. Exploring genomic structure differences and similarities between the Greek and European HapMap populations: implications for association studies. Ann Hum Genet. 2012;76(6):472–483. Study cautioning the use of generalizations when inferring genotype data in different populations. - PubMed
    1. Engen RM, Marsh S, Van Booven DJ, McLeod HL. Ethnic differences in pharmacogenetically relevant genes. Curr Drug Targets. 2006;7(12):1641–1648. - PubMed
    1. Cavaco I, Piedade R, Gil JP, Ribeiro V. CYP2C8 polymorphism among the Portuguese. Clin Chem Lab Med. 2006;44(2):168–170. - PubMed
    1. King CR, Yu J, Freimuth RR, McLeod HL, Marsh S. Interethnic variability of ERCC2 polymorphisms. Pharmacogenomics J. 2005;5(1):54–59. - PubMed

Publication types

LinkOut - more resources